⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVAX News
Novavax Inc
Smart Biosensors Market - Global Forecast 2026-2032 | AI-Enabled Remote Monitoring and Connected Care Drive 6.35% CAGR Toward USD 20.00 Billion by 2032
globenewswire.com
ABT
ADI
BIO
DHR
DXCM
MASI
MDT
NVAX
SENS
TMO
Form 8-K
sec.gov
NVAX
Upstream Bioprocessing Market - Global Size, Trends, and Forecast 2026-2032 | Biologics Demand, AI, and Single-Use Systems Propel 15.21% CAGR and a USD 66.73 Billion Opportunity
globenewswire.com
AVTR
GLW
AMZN
MSFT
GOOG
IBM
TMO
DHR
AMGN
GILD
BMY
REGN
MRK
PFE
JNJ
ABBV
BIIB
MDLZ
CL
PG
KO
PEP
SBUX
MCD
NKE
DIS
HD
CMCSA
VZ
T
XOM
CVX
BA
CAT
GE
HON
LMT
RTX
GD
MMC
AXP
V
MA
BAC
JPM
WFC
C
GS
MS
NVDA
AMD
INTC
QCOM
MU
AMAT
LRCX
ASML
ADI
TXN
ON
NXPI
INFY
WDC
SE
CRSP
EDIT
BEAM
NTLA
BNTX
MRNA
NVAX
BABA
JD
BHP
RIO
VALE
NVS
ROG
AZN
SNY
PAR
EL
ORCL
SAP
CRM
ADBE
NFLX
META
UBER
LYFT
SPGI
MDT
ISRG
ABNB
PYPL
COIN
PLTR
DDOG
SNOW
ZS
CRWD
PANW
FTNT
GOOGL
Dr. Gregory Glenn, CEO van Pinion Immunotherapeutics, spreekt op het World Vaccine Congress Europe 2026 in Amsterdam
businesswire.com
NVAX
Pinion Immunotherapeutics CEO Dr. Gregory Glenn to Speak at World Vaccine Congress Europe 2026 in Amsterdam
businesswire.com
NVAX
Calibration Services Market 2025-2029: Global Forecasts by Type, Industry, Country, and Metropolitan Area | Artificial Intelligence, Regulation, and Outsourcing Fuel Growth and M&A
globenewswire.com
TRNS
FTV
KEYS
LMT
MTD
SI
EMR
BRK.A
GE
AVGO
NVDA
MSFT
GOOGL
IBM
AMD
INTC
ADI
TXN
QCOM
MU
AAPL
MSCI
VITL
DOX
AVT
LII
NEE
XOM
CVX
DVN
APA
COP
EOG
OXY
VRTX
GILD
BMY
PFE
MRK
ABBV
AMGN
BIIB
REGN
AZN
SNY
LLY
JNJ
UNH
CVS
CI
HCA
CNC
ELV
COIN
PYPL
MAR
HPE
DELL
HPQ
CSCO
ACN
TEL
ON
NXPI
MRVL
SNPS
CDNS
SMCI
WDC
SE
ROKU
GOOG
AMZN
CRSP
EDIT
NTLA
BNTX
MRNA
NVAX
ILMN
EXAS
TDOC
NVCR
MDT
SYK
BSX
EW
DUK
SO
PCG
SRE
AEP
EXC
NRG
CEG
XEL
BEP
RUN
PLUG
FCEL
TSLA
NIO
RIVN
LCID
GM
F
STLA
VWAGY
TM
HON
IONQ
RIG
ALKS
ACAD
XBIT
BTBT
MARA
RIOT
ETSY
AMAT
LRCX
KLAC
TER
AEHR
Global Vaccine Adjuvants Market to Reach $3.1 Billion by 2031, Driven by Next-Generation Vaccine Platform Development
globenewswire.com
GSK
NVAX
DVAX
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
globenewswire.com
EBS
GSK
MRK
MRNA
NVAX
PFE
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
prnewswire.com
NVAX
Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors
globenewswire.com
NVAX